Why China's Homegrown Cosmetics Brands Are Still Struggling to Beat Western Giants

Why China's Homegrown Cosmetics Brands Are Still Struggling to Beat Western Giants

Everyone predicted Western beauty conglomerates would be dead in China by now. Five years ago, the narrative seemed airtight. Domestic C-beauty startups were exploding onto Douyin and Xiaohongshu, backed by aggressive venture capital, nationalistic consumer sentiment, and lightning-fast product cycles. L'Oréal and Estée Lauder looked slow, bloated, and out of touch.

That prediction aged terribly.

Walk through a high-end shopping mall in Shanghai or Chengdu today, and the ground floor still belongs to La Mer, Lancôme, and Guerlain. Meanwhile, dozens of once-hyped Chinese cosmetics brands are quietly slashing marketing budgets, fighting brutal price wars on livestream platforms, or shutting down entirely. The reality of China's homegrown cosmetics contenders is much messier than the early "Guochao" (national trend) hype suggested. Building a viral lipstick is easy. Building a multi-billion-dollar beauty empire with real pricing power is an entirely different beast.

The Illusion of the C-Beauty Takeover

Let's look at how we got here. Between 2018 and 2021, domestic Chinese beauty brands experienced a gold rush. Companies like Perfect Diary (owned by Yatsen Holding), Florasis, and Winona capitalized on a massive shift in how young Chinese consumers discovered products. Instead of relying on department store counters or glossy magazine ads, these brands mastered social commerce. They flooded Xiaohongshu with thousands of seeding posts from micro-influencers and dominated Li Jiaqi's livestream sessions.

It worked brilliantly—at first. Yatsen Holding went public on the New York Stock Exchange in November 2020 with a valuation exceeding $12 billion. Investors treated it like the next L'Oréal.

Then the bill came due.

Customer acquisition costs on Chinese social platforms skyrocketed. Traffic on Douyin and Tmall became a pay-to-play auction where platform algorithms extracted almost all the profit margin. When your entire business model depends on constant paid traffic to sell a $15 eyeshadow palette, you don't actually own your customers. You're just renting them from ByteDance and Alibaba. Yatsen's stock price eventually cratered by more than 90 percent from its peak, forcing the company into a painful multi-year restructuring.

Why Marketing Can't Replace R&D

Here's the uncomfortable truth most C-beauty founders ignored during the boom years: packaging and viral marketing only get you the first purchase. Repeat purchases require actual formulation science.

For years, the standard playbook for domestic startups was to outsource manufacturing to giant third-party OEMs and ODMs like Cosmax or Intercos. A brand could conceptualize a new serum, pick an existing base formula from a manufacturer's catalog, slap intricate traditional Chinese artwork on the compact, and launch it in three months.

Western giants play a completely different game. L'Oréal spends over €1 billion annually on research and innovation, employing thousands of scientists who patent proprietary molecules like Pro-Xylane and Mexoryl. Estée Lauder and Shiseido maintain massive patent portfolios built over decades. When a consumer buys a $200 jar of anti-aging cream, they aren't just paying for the brand name. They're buying clinical trial data and patented delivery systems that an OEM factory simply cannot legally replicate for a startup.

Chinese consumers caught on fast. During the economic slowdown following the pandemic, shoppers became far more pragmatic and ingredient-obsessed. Known locally as "ingredient geeks" (chengfendang), these buyers read INCI lists like nutrition labels. They quickly realized that many domestic brands were selling identical OEM formulas under different logos. When money got tight, consumers stopped buying gimmicky packaging. They either traded down to ultra-cheap mass-market basics or saved up for proven international clinical skincare.

The Mid-Market Trap

If you examine the pricing structure of China's beauty sector, domestic players are caught in a brutal squeeze.

At the bottom of the market, ultra-low-cost domestic brands and white-label factory goods compete purely on price. You can buy a functional cleanser or basic moisturizer on Pinduoduo for under 30 RMB (roughly $4). Margins are razor-thin, and brand loyalty is practically nonexistent.

At the top of the market—products priced above 800 RMB ($110)—foreign luxury conglomerates hold an iron grip. Prestige skincare is deeply tied to social status, gifting culture, and perceived safety. A Chinese consumer buying an expensive skincare set for their mother or boss isn't going to risk buying a five-year-old domestic startup. They buy SK-II, Helena Rubinstein, or Clé de Peau Beauté.

This leaves homegrown contenders trapped in the messy middle, fighting for shoppers willing to spend between 150 RMB and 400 RMB. Unfortunately, that exact mid-tier bracket is where consumer spending has contracted the hardest.

The Livestreaming Hangover

Livestream e-commerce promised to democratize retail, yet it ended up acting like a slow poison for brand equity. To get featured by top livestreamers on Taobao or Douyin, brands had to guarantee the "lowest price across the entire internet."

Think about what that does to consumer psychology. If shoppers know your serum will be discounted by 50 percent—plus five free travel-sized samples—during the 618 or Singles' Day shopping festivals, nobody buys at full price during the rest of the year. Brands trained their own customers to wait for steep discounts. Even worse, heavy discounting destroys a brand's ability to ever move upmarket. Once shoppers associate your name with flash sales and giveaways, convincing them to pay luxury prices becomes nearly impossible.

The Few Domestic Brands Actually Winning

Writing off all Chinese cosmetics companies would be a massive mistake. While color cosmetics startups crashed, a specific breed of domestic skincare companies managed to build defensible moats. Look closely at the winners, and a clear pattern emerges.

Proya Cosmetics

Proya is arguably the biggest success story in modern Chinese beauty. Founded back in 2003, the Hangzhou-based company didn't rely on fleeting viral gimmicks. Instead, Proya systematically pivoted toward "hero products" backed by legitimate peptide and retinoid research. Their Ruby Essence and Double Effect Essence became staples for ingredient-conscious shoppers. By maintaining disciplined supply chain control and avoiding the worst excesses of predatory livestream discounting, Proya actually overtook several major international brands in Tmall sales rankings during major shopping festivals.

Botanee Group (Winona)

Yunnan-based Botanee took a completely different route by dominating dermatological skincare for sensitive skin. Their flagship brand, Winona, built credibility through hospital channels and endorsements from Chinese dermatologists long before chasing mass social media traffic. By utilizing proprietary plant extracts native to Yunnan province—like Prinsepia utilis oil—they created a genuine scientific story that foreign competitors couldn't easily copy.

Giant Biogene

If you want to see where the real money is made in C-beauty right now, look at recombinant collagen. Xi'an-based Giant Biogene spent two decades researching bio-fermented collagen technology before launching consumer brands like Comfy (Kefumei). Because they own the core biotech patents and raw material production, their gross margins rival those of European luxury houses—often hovering above 80 percent.

What International Giants Are Doing to Fight Back

Western beauty conglomerates didn't just sit around watching their market share erode. Over the past few years, companies like L'Oréal, Estée Lauder, and Unilever have radically localized their China operations.

L'Oréal opened its massive Suzhou smart fulfillment center and established dedicated venture capital arms like BOLD (Business Opportunities for L'Oréal Development) specifically to invest in emerging Chinese biotech and beauty startups. Instead of waiting two years for Paris headquarters to approve a product tweak, international brands now maintain full-scale R&D and marketing teams in Shanghai that move at Chinese internet speed.

Furthermore, Western giants have used their massive balance sheets to outspend domestic rivals on prestige brand-building. When C-beauty brands were forced to cut offline retail expansion to save cash, L'Oréal and Estée Lauder doubled down on immersive physical boutiques, VIP facial spas, and duty-free dominance in Hainan.

Where C-Beauty Goes From Here

The era of easy growth in China's cosmetics industry is permanently over. The National Medical Products Administration (NMPA) has also tightened regulations dramatically, requiring strict efficacy testing and safety assessments for new ingredients and product claims. That regulatory wall immediately wiped out thousands of low-effort white-label brands that couldn't afford clinical trials.

For investors, founders, and brand strategists watching this space, survival comes down to three non-negotiable moves:

  1. Own the upstream supply chain. Relying on third-party OEM catalogs is a death sentence. Domestic brands must invest in proprietary bio-fermentation, patented peptides, or exclusive botanical extractions to justify premium pricing.
  2. Wean off livestream dependency. Top-funnel awareness on Douyin is still necessary, yet profitable brands are shifting retention toward private traffic (WeChat mini-programs) and selective offline retail experiences where price comparisons aren't instant.
  3. Look beyond mainland China. Several C-beauty players, including Florasis and Judydoll, are aggressively expanding into Japan, Southeast Asia, and North America. Competing abroad forces brands to build genuine brand equity rather than relying on domestic algorithm hacks.

China's homegrown cosmetics contenders aren't disappearing, but the fantasy of an effortless domestic takeover is dead. The brands left standing won't be the ones with the prettiest packaging or the loudest livestreamers—they'll be the ones that actually behave like science companies.

CR

Chloe Ramirez

Chloe Ramirez excels at making complicated information accessible, turning dense research into clear narratives that engage diverse audiences.